Nurix Therapeutics Inc (NRIX)
13.50
-0.46
(-3.30%)
USD |
NASDAQ |
May 10, 16:00
13.50
0.00 (0.00%)
After-Hours: 19:40
Nurix Therapeutics PE Ratio
PE Ratio Chart
Historical PE Ratio Data
Date | Value |
---|
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
Gilead Sciences Inc | 183.28 |
ALX Oncology Holdings Inc | -- |
Vanda Pharmaceuticals Inc | 96.22 |
GlycoMimetics Inc | -- |
Immunic Inc | -- |
PE Ratio Related Metrics
PS Ratio | 9.105 |
Price to Book Value | 4.885 |
Price | 13.50 |
Earnings Yield | -19.70% |
Market Cap | 824.41M |